About this trial
The study aims to review the centre experience in previous 20 years to understand clinical course of patients underwent TLE for lead and pocket infection, to better understand prognosis, re-implant indication, timing and strategy, and long term outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients ≥ 18 years.
Patients who underwent explantation of a single-chamber, dual-chamber, or biventricular pacemaker, or an intracardiac defibrillator, due to pocket infection, lead-related infection, or endocarditis at San Raffaele Hospital between January 2004 and November 2020.
Disqualifiers
Lack of active status of follow-up
Trial population
patients underwent TLE for lead and pocket infection
Trial design
Case-only
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Major clinical adverse outcomes
Cardiovascular mortality
Major clinical adverse outcomes
cardiovascular rehospitalization
Major clinical adverse outcomes
all-cause mortality
Secondary outcomes
need of re-implantation of CIED for patients who underwent TLE
Eventual re-implantation after TLE, during the sane or a following hospitalization. Timing between TLE and re-implantation
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: